Implantable drainage devices in glaucoma: Quo vadis?

Area of Science:

• Ophthalmology
• Biomedical Engineering
• Materials Science

Background:

• Glaucoma is a progressive eye disease characterized by increased intra-ocular pressure (IOP).
• Current treatments like medications and laser surgery have limitations, including poor drug delivery across the blood retinal barrier (BRB) and systemic side effects.
• Frequent high-dose drug administration can lead to ocular damage and reduced patient compliance.

Purpose of the Study:

• To review and compare various implantable devices for glaucoma management.
• To highlight the advantages of implants in reducing IOP and mitigating side effects associated with conventional treatments.
• To discuss the evolution of glaucoma implants from traditional devices to newer micro-invasive options.

Main Methods:

• Comparative analysis of existing literature on glaucoma implants.
• Review of surgical techniques and device mechanisms for fluid outflow enhancement.
• Categorization and critical evaluation of different implant types, including older and newer models.

Main Results:

• Implants provide a viable alternative to conventional therapies, especially when side effects are a concern.
• Glaucoma drainage devices (GDDs) and implantable drainage devices (IDDs) aim to decrease IOP by facilitating aqueous humor outflow.
• A range of implants exist, from established devices like Molteno and Baerveldt to newer micro-invasive options such as iStent and XEN.

Conclusions:

• Eye implants are crucial for managing glaucoma when conventional treatments fail or cause adverse effects.
• These devices offer improved therapeutic outcomes by directly addressing IOP reduction and enhancing patient compliance.
• The development of novel implants continues to advance glaucoma treatment strategies, offering less invasive and more effective solutions.